(210) Results from a phase I, double-blind, randomized, placebo-controlled, multiple-dose study evaluating the safety, tolerability, and pharmacokinetics of oral doses of NKTR-118

2008 ◽  
Vol 9 (4) ◽  
pp. 28 ◽  
Author(s):  
D. Sahner ◽  
H. van Paaschen ◽  
A. Marcantonio ◽  
M. Eldon
Keyword(s):  
Phase I ◽  
Multiple Dose ◽  
Double Blind ◽  
Multiple Dose Study ◽  
Dose Study ◽  
Oral Doses

Fontolizumab in moderate to severe Crohnʼs disease: A phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

2010 ◽  
Vol 16 (2) ◽  
pp. 233-242 ◽  
Author(s):  
Walter Reinisch ◽  
Williem de Villiers ◽  
László Bene ◽  
László Simon ◽  
István Rácz ◽  
...  
Keyword(s):  
Multiple Dose ◽  
Phase 2 ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Multiple Dose Study ◽  
Dose Study

A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese Participants

2018 ◽  
Vol 40 (5) ◽  
pp. 719-732.e1
Author(s):  
Tommy Tsang Cheung ◽  
Joanne Wing Yan Chiu ◽  
Man Fung Yuen ◽  
Karen Siu Ling Lam ◽  
Bernard Man Yung Cheung ◽  
...  
Keyword(s):  
Phase I ◽  
Multiple Dose ◽  
Multiple Dose Study ◽  
Dose Study ◽  
Healthy Chinese

scholarly journals Corrigendum to “A Phase I, Single- and Multiple-dose Study to Evaluate the Pharmacokinetics of Elbasvir and Grazoprevir in Healthy Chinese Participants” [Clinical Therapeutics 40 (2018) 719–732]

2018 ◽  
Vol 40 (9) ◽  
pp. 1618
Author(s):  
Tommy Tsang Cheung ◽  
Joanne Wing Yan Chiu ◽  
Man Fung Yuen ◽  
Karen Siu Ling Lam ◽  
Bernard Man Yung Cheung ◽  
...  
Keyword(s):  
Phase I ◽  
Multiple Dose ◽  
Clinical Therapeutics ◽  
Multiple Dose Study ◽  
Dose Study ◽  
Healthy Chinese
Sign in / Sign up

Export Citation Format

Share Document